Top Markets
#1 MowCat MowCat +368.99%
#2 龙虾 (Lobster) 龙虾 (Lobster) +66.95%
#3 SODAX SODAX +52.29%
#4 Cortex Cortex +33.35%
#5 OpenEden OpenEden +25.58%
#6 DexNet DexNet +23.19%
#7 BNB Attestation Service BNB Attestation Service +20.16%
#8 Magma Finance Magma Finance +17.11%
#9 wojak wojak +16.38%
#10 Akedo Akedo +16.33%
Coin of the day
MowCat MowCat
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Hualan Biological Bacterin Inc. Hualan Biological Bacterin Inc.

Hualan Biological Bacterin Inc.

301207
Kedudukan dalam Saham #7577
Hualan Biological Bacterin Inc. is a Chinese pharmaceutical company focused on... Hualan Biological Bacterin Inc. is a Chinese pharmaceutical company focused on the entire vaccine lifecycle, from research and development to manufacturing and sales within China. The company's product line features a diverse range of immunizations, including various influenza virus vaccines (such as split, quadrivalent, and H1N1 strains), recombinant hepatitis B vaccines, and meningococcal polysaccharide vaccines (including ACYW135 and Group A & C types). They also develop genetically engineered vaccines for human use. Established in 2005, Hualan Biological Bacterin Inc. is headquartered in Xinxiang, China, and previously operated as a subsidiary of Hualan Biological Engineering Inc.
Harga Saham
$2.58
Modal Pasaran
$1.54B
Perubahan (1 hari)
-2.46%
Perubahan (1 tahun)
2.58%
Negara
CN
Perdagangan Hualan Biological Bacterin Inc. (301207)

Kategori

Healthcare
Hasil untuk Hualan Biological Bacterin Inc. (301207)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Hualan Biological Bacterin Inc., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Hualan Biological Bacterin Inc. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH